Saturday, June 22, 2024

Global Trends in Artemisinin Resistance: A Comprehensive Meta-Analysis of K13 Mutations

Similar articles

In the fight against malaria, artemisinin (ART) combination therapy stands as the frontline treatment. However, the efficacy of this treatment is increasingly compromised by the emergence of K13 mutations, known to confer resistance. A systematic review and meta-analysis, recently conducted, provides new insights into the prevalence of these mutations across various malaria-endemic regions, highlighting significant geographical disparities in mutation patterns and resistance levels.

Scope and Methodology of the Study

The study utilized both electronic and manual search strategies to gather data from 170 studies conducted in 2018, with an additional review in 2020. These studies predominantly focused on the prevalence of K13 mutations that contribute to ART resistance. The researchers employed the NIH quality assessment tool for observational cohort and cross-sectional studies to evaluate the risk of bias, ensuring robustness in the data analysis performed using R software and further validated by statistical tests such as I2 and Cochran Q test.

Regional Variations in K13 Mutation Prevalence

Results from the meta-analysis revealed a stark contrast in the prevalence of K13 mutations between regions. Southeast Asia reported the highest prevalence, with the C580Y mutation detected in 35.5% of cases, indicating a severe threat of ART resistance. Conversely, regions such as Africa, South America, Oceania, and other parts of Asia showed significantly lower prevalence rates, with different dominant mutations such as K189T in Africa.

Insights and Implications

  • The high prevalence of C580Y mutation in Southeast Asia necessitates targeted regional strategies to manage and mitigate ART resistance.
  • Lower prevalence rates in Africa and other regions might reflect either underreporting or genuinely slower spread of resistance, meriting continuous surveillance.
  • The diversity in mutation types across regions suggests that global health responses must be tailored to specific mutation patterns to be effective.

This comprehensive review not only maps the current landscape of ART resistance but also underscores the critical need for region-specific interventions to curb the spread of resistant malaria strains. By pinpointing the regions at highest risk and identifying the most prevalent mutations, global health authorities can better allocate resources and strategize more effective containment and treatment measures.

Original Article: Parasitol Res. 2024 May 14;123(5):209. doi: 10.1007/s00436-024-08203-3.

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Latest article